Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
MicroPort CardioFlow Medtech Corp. ( (HK:2160) ) has shared an update.
MicroPort CardioFlow Medtech Corp. has announced a board meeting scheduled for March 27, 2025, to consider and approve the annual results for the year ending December 31, 2024, and to discuss the potential recommendation of a final dividend. This meeting is significant as it will determine the company’s financial performance and potential shareholder returns, impacting its market positioning and stakeholder interests.
More about MicroPort CardioFlow Medtech Corp.
MicroPort CardioFlow Medtech Corp. is a company incorporated in the Cayman Islands, focusing on the medical technology industry with a specialization in cardiovascular products and services.
YTD Price Performance: 66.18%
Average Trading Volume: 2,948,860
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$2.73B
For a thorough assessment of 2160 stock, go to TipRanks’ Stock Analysis page.